文献速递肺血管病与心包/心肌炎血脂与心血管预防

残余胆固醇与LDL胆固醇升高对外周动脉疾病风险的因果影响:孟德尔随机化研究

Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease: A Mendelian Randomization Study.
PubMed 文献 · J Am Coll Cardiol · 2025-01-01

该研究利用英国生物银行全基因组关联研究构建残余胆固醇和LDL胆固醇的遗传评分,采用单变量和多变量孟德尔随机化评估两者对PAD和CAD的因果效应。结果显示,校正LDL胆固醇后,残余胆固醇升高仍对PAD有因果效应(多变量OR 2.16),而LDL胆固醇对PAD的因果效应大部分依赖于同时升高的残余胆固醇(多变量OR 1.14)。提示残余胆固醇可能是PAD风险增加的主要胆固醇成分。

要点

  • 残余胆固醇升高对PAD有独立于LDL胆固醇的因果效应。
  • LDL胆固醇对PAD的因果效应大部分依赖于残余胆固醇同时升高。
  • 残余胆固醇可能是PAD风险增加的主要胆固醇成分。

核心结论

  • 残余胆固醇升高对PAD风险有因果效应,且独立于LDL胆固醇。
  • LDL胆固醇对PAD的因果效应大部分依赖于同时升高的残余胆固醇。
  • 残余胆固醇可能是导致PAD风险增加的主要胆固醇成分。

研究设计与样本

  • 研究采用孟德尔随机化设计,利用英国生物银行全基因组关联研究识别的基因变异构建残余胆固醇和LDL胆固醇遗传评分。
  • PAD分析纳入38,414例病例和758,308例对照;CAD分析纳入221,445例病例和770,615例对照。
  • 采用单变量和多变量孟德尔随机化估计因果效应。

主要发现

  • 残余胆固醇和LDL胆固醇每升高1 mmol/L(39 mg/dL),单变量PAD的OR分别为2.72(95%CI 2.10-3.52)和1.37(95%CI 1.25-1.51)。
  • 多变量分析中,残余胆固醇和LDL胆固醇每升高1 mmol/L,PAD的OR分别为2.16(95%CI 1.49-3.12)和1.14(95%CI 1.00-1.30)。
  • CAD单变量OR分别为2.92(95%CI 2.34-3.64)和1.67(95%CI 1.56-1.79),多变量OR分别为1.86(95%CI 1.39-2.47)和1.44(95%CI 1.29-1.60)。
  • 按1 SD增量缩放,PAD单变量OR分别为1.37(95%CI 1.27-1.49)和1.29(95%CI 1.20-1.39),多变量OR分别为1.28(95%CI 1.14-1.43)和1.11(95%CI 1.00-1.23)。
  • CAD按1 SD增量缩放,单变量OR分别为1.40(95%CI 1.31-1.51)和1.51(95%CI 1.43-1.59),多变量OR分别为1.22(95%CI 1.11-1.33)和1.34(95%CI 1.23-1.46)。

临床怎么用

  • 在评估PAD风险时,除LDL胆固醇外,应关注残余胆固醇水平。
  • 残余胆固醇可能是PAD预防和治疗的潜在靶点。

局限性

  • 研究结果基于遗传学工具变量,需进一步研究生物学机制。
  • 未来需探索改进PAD预防和治疗的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated remnant cholesterol and low-density lipoprotein (LDL) cholesterol both increase the risk of coronary artery disease (CAD), but it is not known if the same is true for peripheral artery disease (PAD). OBJECTIVES: This study tested the hypothesis that elevated remnant cholesterol and LDL cholesterol, each independent of the other, have causal effects on risk of PAD. METHODS: The authors constructed genetic scores from variants near genes known to directly affect levels of remnant cholesterol and LDL cholesterol, identified through a genome-wide association study of individuals in the UK Biobank. Univariable (remnant cholesterol and LDL cholesterol genetic scores separately) and multivariable (remnant cholesterol and LDL cholesterol genetic scores combined) Mendelian randomization were used to estimate the causal effects of higher remnant cholesterol and LDL cholesterol levels on ORs for PAD (n = 38,414 cases and 758,308 controls) and CAD (n = 221,445 cases and 770,615 controls). RESULTS: Increments in remnant and LDL genetic scores corresponding to 1 mmol/L (39 mg/dL) higher remnant and LDL cholesterol, respectively, were associated with univariable ORs for PAD of 2.72 (95% CI: 2.10-3.52) and 1.37 (95% CI: 1.25-1.51); corresponding multivariable ORs were 2.16 (95% CI: 1.49-3.12) and 1.14 (95% CI: 1.00-1.30). For CAD, corresponding univariable ORs were 2.92 (95% CI: 2.34-3.64) and 1.67 (95% CI: 1.56-1.79), whereas multivariable ORs were 1.86 (95% CI: 1.39-2.47) and 1.44 (95% CI: 1.29-1.60). Scaled to 1 SD increments in remnant cholesterol and LDL cholesterol, corresponding univariable ORs were 1.37 (95% CI: 1.27-1.49) and 1.29 (95% CI: 1.20-1.39) for PAD, and 1.40 (95% CI: 1.31-1.51) and 1.51 (95% CI: 1.43-1.59) for CAD; corresponding multivariable ORs were 1.28 (95% CI: 1.14-1.43) and 1.11 (95% CI: 1.00-1.23) for PAD, and 1.22 (95% CI: 1.11-1.33) and 1.34 (95% CI: 1.23-1.46) for CAD. CONCLUSIONS: Elevated remnant cholesterol had a causal effect on risk of PAD even after accounting for elevated LDL cholesterol, whereas most of the causal effect of elevated LDL cholesterol on risk of PAD was dependent on simultaneously elevated remnant cholesterol. These results indicate that remnant cholesterol may be the major cholesterol fraction responsible for increased risk of PAD. Future studies should investigate the biological mechanisms behind these findings to find improved therapies for prevention and treatment of PAD.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wadström BN, Borges MC, Wulff AB, et al. Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease: A Mendelian Randomization Study. J Am Coll Cardiol. 2025. PMID: 40139892. doi:10.1016/j.jacc.2024.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。